Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis | Zendy

Margitta Worm | Zendy; Eric L. Simpson | Zendy; Diamant Thaçi | Zendy; Robert Bissonnette | Zendy; J.P. Lacour | Zendy; Stefan Beissert | Zendy; Makoto Kawashima | Zendy; Carlos Ferrándiz | Zendy; Catherine Smith | Zendy; Lisa A. Beck | Zendy; KuoChen Chan | Zendy; Zhen Chen | Zendy; Bolanle Akinlade | Zendy; Thomas Hultsch | Zendy; Heribert Staudinger | Zendy; Abhijit Gadkari | Zendy; Laurent Eckert | Zendy; John D. Davis | Zendy; Manoj Rajadhyaksha | Zendy; Neil M.H. Graham | Zendy; Gianluca Pirozzi | Zendy; Neil Stahl | Zendy; George D. Yancopoulos | Zendy; Marius Ardeleanu | Zendy

Open Access

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

Author(s) -

Margitta Worm,

Eric L. Simpson,

Diamant Thaçi,

Robert Bissonnette,

J.P. Lacour,

Stefan Beissert,

Makoto Kawashima,

Carlos Ferrándiz,

Catherine Smith,

Lisa A. Beck,

KuoChen Chan,

Zhen Chen,

Bolanle Akinlade,

Thomas Hultsch,

Heribert Staudinger,

Abhijit Gadkari,

Laurent Eckert,

John D. Davis,

Manoj Rajadhyaksha,

Neil M.H. Graham,

Gianluca Pirozzi,

Neil Stahl,

George D. Yancopoulos,

Marius Ardeleanu

Publication year - 2019

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2019.3617

Subject(s) - dupilumab , medicine , atopic dermatitis , dermatology

The dupilumab regimen of 300 mg every 2 weeks is approved for uncontrolled, moderate to severe atopic dermatitis (AD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore